ARCHIVES

IOM Report Calls For FDA Authority Nutritional Supplement Health Claims

This article is from The Cancer Letter archive.

Vol. 36 No. 19 | May 21, 2010

Download PDF Visit The Full Archive

Related Articles

Cancer Panel Statement On Access To Cancer Care.

October 6, 2000

In Brief: fraud By Trainee Leads Collins To Retract Five Paper; Weinstein Retires At Columbia

November 1, 1996

Clinical Trials Approved By NCI’s CTEP Listed

February 25, 2005

Center Review By Panel, NCI Leading To Changes; Hammer Tells NCAB It Faces “Difficult Decision”

December 13, 1984

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

NCI Advisory Group, Other Cancer Meetings

January 30, 1976